Clinical trial
ReoPro and Retavase to Restore Brain Blood Flow After Stroke
NCT00039832 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00039832 |
|---|---|
| Title | ReoPro and Retavase to Restore Brain Blood Flow After Stroke |
| Official title | ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | Abciximab (ReoPro) and Reteplase (Retavase) |
| Enrollment | 42 |
| Start date | Mar 1, 2002 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Jun 13, 2002 |
| Last update posted | Sep 21, 2011 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: